Sanofi - SPONSORED ADR (SNY)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q2 2024
271M
Holdings value Q2 2024
$13.2B
Value change Q2 2024
+$734M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
704
Number of buys Q2 2024
130
Number of sells Q2 2024
-112
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 11.7M $673M +$6.38M $57.63 294
2024 Q2 271M $13.2B +$734M $48.52 705
2024 Q1 256M $12.5B +$459M $48.60 692
2023 Q4 246M $12.2B -$253M $49.73 688
2023 Q3 251M $13.5B -$169M $53.64 677
2023 Q2 254M $13.7B -$664M $53.90 658
2023 Q1 264M $14.3B +$292M $54.42 657
2022 Q4 261M $12.6B +$342M $48.43 625
2022 Q3 254M $9.67B -$224M $38.02 558
2022 Q2 258M $12.9B +$532M $50.03 634
2022 Q1 251M $12.9B +$355M $51.34 607
2021 Q4 244M $12.2B +$342M $50.10 610
2021 Q3 236M $11.4B +$1.64B $48.21 568
2021 Q2 202M $10.6B +$297M $52.66 574
2021 Q1 197M $9.72B +$1.14B $49.46 560
2020 Q4 175M $8.48B +$62.3M $48.59 590
2020 Q3 173M $8.67B -$298M $50.17 562
2020 Q2 179M $9.13B -$396M $51.05 571
2020 Q1 186M $8.16B +$342M $43.72 533
2019 Q4 179M $9B +$33.3M $50.20 519
2019 Q3 179M $8.27B +$158M $46.33 478
2019 Q2 175M $7.58B -$253M $43.27 476
2019 Q1 181M $8.03B +$105M $44.28 487
2018 Q4 179M $7.76B +$82M $43.41 496
2018 Q3 177M $7.89B -$512M $44.67 478
2018 Q2 189M $7.55B -$948M $40.01 475
2018 Q1 213M $8.52B -$560M $40.08 483
2017 Q4 226M $9.7B -$178M $43.00 496
2017 Q3 229M $11.4B -$297M $49.79 476
2017 Q2 235M $11.3B -$670M $47.91 468
2017 Q1 250M $11.3B +$51M $45.25 450
2016 Q4 250M $10.1B -$114M $40.44 472
2016 Q3 253M $9.65B +$379M $38.19 442
2016 Q2 242M $10.1B +$510M $41.85 444
2016 Q1 231M $9.32B +$92.8M $40.16 441
2015 Q4 228M $9.73B -$542M $42.65 473
2015 Q3 241M $11.4B -$462M $47.47 490
2015 Q2 252M $12.5B -$257M $49.53 493
2015 Q1 257M $12.7B +$434M $49.44 509
2014 Q4 249M $11.4B +$340M $45.61 492
2014 Q3 241M $13.6B +$166M $56.43 495
2014 Q2 238M $12.6B +$109M $53.17 484
2014 Q1 236M $12.3B +$595M $52.28 487